EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study

Go back to EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 33.88 --0 (-0%)
Previous Close $33.88    52 Week High $5.09 
Open $33.88    52 Week Low $1.11 
Day High $33.88    P/E N/A 
Day Low $33.88    EPS $0.00 
Volume 2